LS_LBP_003

N/A

Report date: 2024/12/04 10:14:36

Base Information

Drug NameLS_LBP_003
Drug Alias NameLS_LBP_003LS-LBP-003LBP_003LBP-003
ClassificationBiologics > Live Biotherapeutic
Mechanisms of ActionGastrointestinal microbiome modulatorsBacteria replacements
TargetsUpdating
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Lishan Biopharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Lishan Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A